✦ LIBER ✦

Second trial drugs in ovarian cancer

✍ Scribed by C.Robert Stanhope; Julian P. Smith; Felix Rutledge

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line randomized trials in epithel

✍ J.B. VERMORKEN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

ZD0473 phase II monotherapy trial in sec

✍ M. Gore; R.J. Atkinson; L. Dirix; D. Rischin; P. Beale; P. Harnet; D. Hacking; H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Antiangiogenic drugs in ovarian cancer

✍ Kumaran, G C; Jayson, G C; Clamp, A R 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Targeted trials in ovarian cancer

✍ Jonathan A. Ledermann; Fharat A. Raja 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 189 KB

New drugs for ovarian cancer

✍ Bell-McGuinn, K.; Konner, J.; Tew, W.; Spriggs, D. R. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 101 KB

Emerging drugs for ovarian cancer

✍ Kelland, Lloyd R 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 185 KB